Abstract:Cardiac hypertrophy is initially an adaptive response to increased hemodynamic workload or defective contractile machinery; however, in the long‐term, it contributes to heart failure and sudden cardiac death. The extracellular regulatory factors and intracellular signaling pathways involved are not fully clear. Here, we studied the chronic effect of Ang II infusion on cardiac hypertrophy and fibrosis, and evaluated the role of class I PI3‐kinase in these actions of Ang II using lentiviral vector‐mediated expression of a dominant negative form of Class I PI3‐kinase subunit p85α in the heart of rats. Subcutaneous 4‐week infusion of Ang II induced severe cardiac hypertrophy and perivascular fibrosis in the heart. Cardiac transduction of Lv‐DNp85 abolished Ang II‐induced phosphorylation of Akt in the heart, as well as Ang II‐induced cardiac hypertrophy and perivascular fibrosis. Next, we examined intracellular mechanisms underlying Ang II‐induced cardiac hypertrophy in cultured cardiomyocytes. It is well known that mitochondrial oxidative stress mediates Ang II‐induced cardiac hypertrophy and the major source of reactive oxygen species (ROS), damaged mitochondria, is cleared by autophagy (also called mitophagy) in cardiac myocytes. Treatment of cardiomyocytes with Ang II (10−9 to 10−5 M) significantly increased autophagy with two phases (increases at low doses, decreases at high doses, peaked at 10−7 M). Ang II (10−6 M)‐induced increases in autophagy were significantly potentiated by PI3‐kinase Class I inhibitor, LY294002 (1 μM) and dramatically attenuated by 3‐Methyladenine (3‐MA, 1 μM), a PI3‐kinase Class III inhibitor. Ang II‐induced mitochondrial ROS production, measured using MitoSOX, was attenuated by LY294002 and potentiated by 3‐MA significantly. PI3‐kinases activity were measured using ELISA in cardiomyocytes, demonstrating that Ang II (10−6 M, i.e. high dose) significantly increased the activity of both Class I and Class III PI3‐kinases; however, Ang II (10−9 M, i.e. low dose) selectively elevated PI3‐kinase Class III activity. Together these data suggest that Ang II could have dual effects in the heart: 1) a protective arm to prevent ROS over‐generation in physiological cardiac hypertrophy, which is mediated by a Class III PI3‐kinase/autophagy‐dependent pathway; and 2) a deleterious arm due to increased mitochondrial ROS production through inhibition of autophagy by a Class I PI3‐kinase pathway in cardiomyocytes.Support or Funding InformationSupported by NIH NS55008.This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Class Iii Pi3k-Mediated Prolonged Activation Of Autophagy Plays A Critical Role In The Transition Of Cardiac Hypertrophy To Heart Failure

Role of PI3‐kinase in Angiotensin II‐induced Cardiac Hypertrophy: Shift from Class III to Class I

Class III PI3‐Kinase in Angiotensin II‐Induced Cardiac Hypertrophy

Chronic Blockade of Class I Pi3-Kinase Attenuates Ang Ii-Induced Cardiac Hypertrophy and Autophagic Alteration

Restored autophagy is protective against PAK3-induced cardiac dysfunction

Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.

Selective activation of PI3K /Akt/GSK-3 signalling and cardiac compensatory hypertrophy during recovery from heart failure

Selective activation of PI3Kα/Akt/GSK‐3β signalling and cardiac compensatory hypertrophy during recovery from heart failure

Cardiac autophagy is a maladaptive response to hemodynamic stress.

The Role of Autophagy in Cardiac Hypertrophy.

CaMKII Exacerbates Heart Failure Progression by Activating Class I HDACs.

Downregulation of Survival Signalling Pathways and Increased Apoptosis in the Transition of Pressure Overload‐induced Cardiac Hypertrophy to Heart Failure

The Effects of Survival Signaling Pathways in Pressure Overload-induced Cardiomyopathy and Heart Failure in Mice

AMPK blunts chronic heart failure by inhibiting autophagy.

Different Roles Of Bag3 In Cardiac Physiological Hypertrophy And Pathological Remodeling

Tumor Necrosis Factor Receptor-Associated Factor 3 is A Positive Regulator of Pathological Cardiac Hypertrophy

Mouse Sirt3 Promotes Autophagy in AngII-induced Myocardial Hypertrophy Through the Deacetylation of FoxO1.

Focal Adhesion Kinase-mediated Phosphorylation of Beclin1 Protein Suppresses Cardiomyocyte Autophagy and Initiates Hypertrophic Growth

Deficiency of Diacylglycerol Kinase Ζ Promotes Beclin1-mediated Autophagy Via the Mtor/tfeb Signaling Pathway: Relevance to Maladaptive Cardiac Hypertrophy

Up-regulating Autophagy by Targeting the Mtor-4Ebp1 Pathway: a Possible Mechanism for Improving Cardiac Function in Mice with Experimental Dilated Cardiomyopathy

DGKζ Deficiency Promotes Maladaptive Cardiac Hypertrophy Through Modulating Autophagy Via Mtor/tfeb Signaling Pathway